Arcoma Aktiebolag convenes an extraordinary general meeting on November 25 to propose a board authorization for share buybacks and transfers, aiming to enhance capital flexibility and support future growth initiatives.
The notice to the extraordinary general meeting proposes authorizing the board to acquire and transfer own shares, a routine capital structure measure with neutral expected impact.
Arcoma Aktiebolag has scheduled an extraordinary general meeting for November 25, 2026, in Stockholm. The board seeks shareholder authorization to acquire and transfer up to 10% of the company's outstanding shares to optimize capital structure and facilitate potential acquisitions.
The meeting is primarily called to authorize the board of directors to acquire and transfer the company's own shares to adjust capital structure and fund potential acquisitions.